Skip to main content
AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
20.31
+0.34 (1.70%)
Nov 20, 2024, 4:00 PM EST - Market closed

AnaptysBio Revenue

AnaptysBio had revenue of $30.02M in the quarter ending September 30, 2024, with 804.67% growth. This brings the company's revenue in the last twelve months to $57.17M, up 282.17% year-over-year. In the year 2023, AnaptysBio had annual revenue of $17.16M with 66.78% growth.

Revenue (ttm)
$57.17M
Revenue Growth
+282.17%
P/S Ratio
9.74
Revenue / Employee
$488,650
Employees
117
Market Cap
618.01M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202317.16M6.87M66.78%
Dec 31, 202210.29M-52.89M-83.72%
Dec 31, 202163.18M-11.83M-15.77%
Dec 31, 202075.00M67.00M837.50%
Dec 31, 20198.00M3.00M60.00%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 832.70M
Butterfly Network 76.22M
CureVac 70.57M
Phathom Pharmaceuticals 26.27M
Immunome 10.13M
ABIVAX Société Anonyme 9.68M
Revenue Rankings

ANAB News

More News